Proto Labs Files 8-K on Officer Changes & Compensation
Ticker: PRLB · Form: 8-K · Filed: Oct 3, 2025 · CIK: 1443669
| Field | Detail |
|---|---|
| Company | Proto Labs Inc (PRLB) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, filing
TL;DR
Proto Labs 8-K: Leadership changes and compensation details filed Oct 3, 2025.
AI Summary
Proto Labs, Inc. filed an 8-K on October 3, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in company leadership and executive compensation, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing is routine and reports on standard corporate governance and disclosure items without immediate financial implications.
Key Numbers
- 001-35435 — SEC File Number (Identifies the company's filing with the SEC.)
- 41-1939628 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Proto Labs, Inc. (company) — Registrant
- October 3, 2025 (date) — Date of earliest event reported
- Minnesota (location) — State of incorporation
- 5540 Pioneer Creek Drive (address) — Principal executive offices
- Maple Plain (location) — City of principal executive offices
- 55359 (zip_code) — Zip code of principal executive offices
FAQ
What specific officer positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific positions are not detailed in the provided text.
Are there any details on the new compensatory arrangements for officers mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specifics of these arrangements are not included in the provided excerpt.
What is the significance of the 'Regulation FD Disclosure' item?
This indicates that the company is making public disclosures to prevent selective disclosure of material non-public information.
What types of financial statements and exhibits are included with this filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific nature of these documents is not detailed in the provided text.
When was Proto Labs, Inc. incorporated?
Proto Labs, Inc. was incorporated in Minnesota, as stated in the filing.
Filing Stats: 648 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2025-10-03 10:41:51
Key Financial Figures
- $0.001 — ch registered Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchang
Filing Documents
- tm2527871d1_8k.htm (8-K) — 33KB
- tm2527871d1_ex99-1.htm (EX-99.1) — 10KB
- tm2527871d1_ex99-1img001.jpg (GRAPHIC) — 36KB
- tm2527871d1_ex99-1img002.jpg (GRAPHIC) — 22KB
- 0001104659-25-096447.txt ( ) — 287KB
- prlb-20251003.xsd (EX-101.SCH) — 3KB
- prlb-20251003_lab.xml (EX-101.LAB) — 33KB
- prlb-20251003_pre.xml (EX-101.PRE) — 22KB
- tm2527871d1_8k_htm.xml (XML) — 3KB
02
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 3, 2025 (the "Notice Date"), Proto Labs, Inc. (the "Company") announced that Oleg Ryaboy, Chief Technology Officer, will depart the Company and cease to be an employee, effective November 2, 2025. As of the Notice Date, Mr. Ryaboy is no longer the Company's Chief Technology Officer or an executive officer of the Company. Marc Kermisch has been appointed to serve as the Company's new Chief Technology & AI Officer, effective October 13, 2025. Upon his departure, Mr. Ryaboy will be entitled to receive the severance benefits described in Section 5(A) of the Company's Form of Executive Severance Agreement filed as Exhibit 99.2 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 6, 2022.
01
Item 7.01. Regulation FD Disclosure. On the Notice Date, the Company issued a press release announcing the leadership transition described in Item 5.02 above. A copy of the press release is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in that filing.
01. Financial
Item 9.01. Financial (d) Exhibits Exhibit No. Description 99.1 Press release, dated October 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTO LABS, INC. Date: October 3, 2025 /s/ Daniel Schumacher Daniel Schumacher Chief Financial Officer